摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Methyl-2-[4-piperazin-1-yl-8-(3,4,5-trimethoxy-benzyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-ylamino]-thiazole-5-carboxylic acid ethyl ester

中文名称
——
中文别名
——
英文名称
4-Methyl-2-[4-piperazin-1-yl-8-(3,4,5-trimethoxy-benzyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-ylamino]-thiazole-5-carboxylic acid ethyl ester
英文别名
Ethyl 4-methyl-2-[[4-piperazin-1-yl-8-[(3,4,5-trimethoxyphenyl)methyl]-6,7-dihydropyrimido[5,4-b][1,4]oxazin-2-yl]amino]-1,3-thiazole-5-carboxylate
4-Methyl-2-[4-piperazin-1-yl-8-(3,4,5-trimethoxy-benzyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-ylamino]-thiazole-5-carboxylic acid ethyl ester化学式
CAS
——
化学式
C27H35N7O6S
mdl
——
分子量
585.684
InChiKey
YHHHXYFWLHDBNL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    41
  • 可旋转键数:
    11
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    161
  • 氢给体数:
    2
  • 氢受体数:
    14

反应信息

  • 作为产物:
    描述:
    2-[4-Chloro-8-(3,4,5-trimethoxy-benzyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-ylamino]-4-methyl-thiazole-5-carboxylic acid ethyl ester 、 哌嗪正丁醇 为溶剂, 生成 4-Methyl-2-[4-piperazin-1-yl-8-(3,4,5-trimethoxy-benzyl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-2-ylamino]-thiazole-5-carboxylic acid ethyl ester
    参考文献:
    名称:
    Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): synthesis and initial structure–activity relationships
    摘要:
    A series of fused pyrimidine based inhibitors of PDE7 have been derived from an earlier screening lead 1. The synthesis, structure-activity relationships (SAR) and selectivity against several other PDE family members are described. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.02.025
点击查看最新优质反应信息

文献信息

  • Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): synthesis and initial structure–activity relationships
    作者:James Kempson、William J. Pitts、Joseph Barbosa、Junqing Guo、Omonike Omotoso、Andrew Watson、Karen Stebbins、Gary C. Starling、John H. Dodd、Joel C. Barrish、Raymond Felix、Karl Fischer
    DOI:10.1016/j.bmcl.2005.02.025
    日期:2005.4
    A series of fused pyrimidine based inhibitors of PDE7 have been derived from an earlier screening lead 1. The synthesis, structure-activity relationships (SAR) and selectivity against several other PDE family members are described. (c) 2005 Elsevier Ltd. All rights reserved.
查看更多